Literature DB >> 28159893

Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection.

Geetha H Mylvaganam1,2, Daniel Rios3, Hadia M Abdelaal4,5, Smita Iyer2, Gregory Tharp2, Maud Mavigner6, Sakeenah Hicks2, Ann Chahroudi6, Rafi Ahmed7,2, Steven E Bosinger2, Ifor R Williams3, Pamela J Skinner4, Vijayakumar Velu8, Rama R Amara7,2.   

Abstract

A significant challenge to HIV eradication is the elimination of viral reservoirs in germinal center (GC) T follicular helper (Tfh) cells. However, GCs are considered to be immune privileged for antiviral CD8 T cells. Here, we show a population of simian immunodeficiency virus (SIV)-specific CD8 T cells express CXCR5 (C-X-C chemokine receptor type 5, a chemokine receptor required for homing to GCs) and expand in lymph nodes (LNs) following pathogenic SIV infection in a cohort of vaccinated macaques. This expansion was greater in animals that exhibited superior control of SIV. The CXCR5+ SIV-specific CD8 T cells demonstrated enhanced polyfunctionality, restricted expansion of antigen-pulsed Tfh cells in vitro, and possessed a unique gene expression pattern related to Tfh and Th2 cells. The increase in CXCR5+ CD8 T cells was associated with the presence of higher frequencies of SIV-specific CD8 T cells in the GC. Following TCR-driven stimulation in vitro, CXCR5+ but not CXCR5- CD8 T cells generated both CXCR5+ as well as CXCR5- cells. However, the addition of TGF-β to CXCR5- CD8 T cells induced a population of CXCR5+ CD8 T cells, suggesting that this cytokine may be important in modulating these CXCR5+ CD8 T cells in vivo. Thus, CXCR5+ CD8 T cells represent a unique subset of antiviral CD8 T cells that expand in LNs during chronic SIV infection and may play a significant role in the control of pathogenic SIV infection.

Entities:  

Keywords:  CXCR5+CD8+ T cells; HIV; SIV; follicular CD8 T cells; lymphoid follicles

Mesh:

Substances:

Year:  2017        PMID: 28159893      PMCID: PMC5338410          DOI: 10.1073/pnas.1621418114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

2.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

3.  CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection.

Authors:  Suefen Kwa; Shanmugalakshmi Sadagopal; Xiaoying Shen; Jung Joo Hong; Sailaja Gangadhara; Rahul Basu; Blandine Victor; Smita S Iyer; Celia C LaBranche; David C Montefiori; Georgia D Tomaras; Francois Villinger; Bernard Moss; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.

Authors:  Sunil Kannanganat; Bill G Kapogiannis; Chris Ibegbu; Lakshmi Chennareddi; Paul Goepfert; Harriet L Robinson; Jeffrey Lennox; Rama Rao Amara
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

7.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

8.  Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa.

Authors:  Geetha H Mylvaganam; Vijayakumar Velu; Jung-Joo Hong; Shanmugalakshmi Sadagopal; Suefen Kwa; Rahul Basu; Benton Lawson; Francois Villinger; Rama Rao Amara
Journal:  J Immunol       Date:  2014-09-22       Impact factor: 5.422

9.  Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.

Authors:  G Poli; A L Kinter; J S Justement; P Bressler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.

Authors:  Matthieu Perreau; Anne-Laure Savoye; Elisa De Crignis; Jean-Marc Corpataux; Rafael Cubas; Elias K Haddad; Laurence De Leval; Cecilia Graziosi; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2012-12-17       Impact factor: 14.307

View more
  68 in total

1.  Identification and characterization of HIV-specific resident memory CD8+ T cells in human lymphoid tissue.

Authors:  Marcus Buggert; Son Nguyen; Gonzalo Salgado-Montes de Oca; Bertram Bengsch; Samuel Darko; Amy Ransier; Emily R Roberts; Daniel Del Alcazar; Irene Bukh Brody; Laura A Vella; Lalit Beura; Sathi Wijeyesinghe; Ramin S Herati; Perla M Del Rio Estrada; Yuria Ablanedo-Terrazas; Leticia Kuri-Cervantes; Alberto Sada Japp; Sasikanth Manne; Shant Vartanian; Austin Huffman; Johan K Sandberg; Emma Gostick; Gregory Nadolski; Guido Silvestri; David H Canaday; David A Price; Constantinos Petrovas; Laura F Su; Golnaz Vahedi; Yoav Dori; Ian Frank; Maxim G Itkin; E John Wherry; Steven G Deeks; Ali Naji; Gustavo Reyes-Terán; David Masopust; Daniel C Douek; Michael R Betts
Journal:  Sci Immunol       Date:  2018-06-01

2.  Whole body MRI of the non-human primate using a clinical 3T scanner: initial experiences.

Authors:  Chun-Xia Li; Xiaodong Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-04

Review 3.  CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Authors:  Laura A Vella; Ramin S Herati; E John Wherry
Journal:  Trends Mol Med       Date:  2017-11-12       Impact factor: 11.951

Review 4.  Follicular T-cell subsets in HIV infection: recent advances in pathogenesis research.

Authors:  Yin Xu; Matthew T Ollerton; Elizabeth Connick
Journal:  Curr Opin HIV AIDS       Date:  2019-03       Impact factor: 4.283

5.  Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.

Authors:  Ann J Hessell; Mariya B Shapiro; Rebecca Powell; Delphine C Malherbe; Sean P McBurney; Shilpi Pandey; Tracy Cheever; William F Sutton; Christoph Kahl; Byung Park; Susan Zolla-Pazner; Nancy L Haigwood
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

Review 6.  Here, there and everywhere: T follicular helper cells on the move.

Authors:  Cindy S Ma; Tri Giang Phan
Journal:  Immunology       Date:  2017-08-07       Impact factor: 7.397

7.  Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control.

Authors:  Mohammad Arif Rahman; Katherine M McKinnon; Tatiana S Karpova; David A Ball; David J Venzon; Wenjin Fan; Guobin Kang; Qingsheng Li; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

8.  Accumulation of follicular CD8+ T cells in pathogenic SIV infection.

Authors:  Sara Ferrando-Martinez; Eirini Moysi; Amarendra Pegu; Sarah Andrews; Krystelle Nganou Makamdop; David Ambrozak; Adrian B McDermott; David Palesch; Mirko Paiardini; George N Pavlakis; Jason M Brenchley; Daniel Douek; John R Mascola; Constantinos Petrovas; Richard A Koup
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

Review 9.  Bispecific antibodies: Potential immunotherapies for HIV treatment.

Authors:  Giulia Fabozzi; Amarendra Pegu; Richard A Koup; Constantinos Petrovas
Journal:  Methods       Date:  2018-10-22       Impact factor: 3.608

10.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.